Nanoparticle-Protein Corona Complex: Understanding Multiple Interactions Between Environmental Factors, Corona Formation, and Biological Activity
| dc.contributor.author | Tomak, Aysel | |
| dc.contributor.author | Tomak, Aysel | |
| dc.contributor.author | Çesmeli, Selin | |
| dc.contributor.author | Öksel Karakuş, Ceyda | |
| dc.contributor.author | Hanoglu, Bercem D. | |
| dc.contributor.author | Winkler, David | |
| dc.contributor.author | Oksel Karakus, Ceyda | |
| dc.date.accessioned | 2024-01-06T07:21:24Z | |
| dc.date.available | 2024-01-06T07:21:24Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | The surfaces of pristine nanoparticles become rapidly coated by proteins in biological fluids, forming the so-called protein corona. The corona modifies key physicochemical characteristics of nanoparticle surfaces that modulate its biological and pharmacokinetic activity, biodistribution, and safety. In the two decades since the protein corona was identified, the importance of nanoparticles surface properties in regulating biological responses have been recognized. However, there is still a lack of clarity about the relationships between physiological conditions and corona composition over time, and how this controls biological activities/interactions. Here we review recent progress in characterizing the structure and composition of protein corona as a function of biological fluid and time. We summarize the influence of nanoparticle characteristics on protein corona composition and discuss the relevance of protein corona to the biological activity and fate of nanoparticles. The aim is to provide a critical summary of the key factors that affect protein corona formation (e.g. characteristics of nanoparticles and biological environment) and how the corona modulates biological activity, cellular uptake, biodistribution, and drug delivery. In addition to a discussion on the importance of the characterization of protein corona adsorbed on nanoparticle surfaces under conditions that mimic relevant physiological environment, we discuss the unresolved technical issues related to the characterization of nanoparticle-protein corona complexes during their journey in the body. Lastly, the paper offers a perspective on how the existing nanomaterial toxicity data obtained from in vitro studies should be reconsidered in the light of the presence of a protein corona, and how recent advances in fields, such as proteomics and machine learning can be integrated into the quantitative analysis of protein corona components. | en_US |
| dc.description.sponsorship | 2232 International Fellowship for Outstanding Researchers Program of TUBITAK [118C229] | en_US |
| dc.description.sponsorship | This paper has been produced benefiting from the 2232 International Fellowship for Outstanding Researchers Program of TUBITAK, project No: 118C229. | en_US |
| dc.identifier.doi | 10.1080/17435390.2022.2025467 | |
| dc.identifier.issn | 1743-5390 | |
| dc.identifier.issn | 1743-5404 | |
| dc.identifier.uri | https://doi.org/10.1080/17435390.2022.2025467 | |
| dc.identifier.uri | https://hdl.handle.net/11147/14118 | |
| dc.language.iso | en | en_US |
| dc.publisher | TAYLOR & FRANCIS LTD | en_US |
| dc.relation.ispartof | Nanotoxicology | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Protein corona | en_US |
| dc.subject | nanoparticles | en_US |
| dc.subject | nanomaterials | en_US |
| dc.subject | protein corona characterization | en_US |
| dc.subject | biological activity | en_US |
| dc.subject | Dependent Cellular Uptake | en_US |
| dc.subject | Silver Nanoparticles | en_US |
| dc.subject | Silica Nanoparticles | en_US |
| dc.subject | Gold Nanoparticles | en_US |
| dc.subject | Carbon Nanotubes | en_US |
| dc.subject | Biomolecule Corona | en_US |
| dc.subject | Surface-Chemistry | en_US |
| dc.subject | Drug-Delivery | en_US |
| dc.subject | Particle-Size | en_US |
| dc.subject | Cytotoxicity | en_US |
| dc.title | Nanoparticle-Protein Corona Complex: Understanding Multiple Interactions Between Environmental Factors, Corona Formation, and Biological Activity | en_US |
| dc.type | Review | en_US |
| dspace.entity.type | Publication | |
| gdc.author.id | Winkler, David / 0000-0002-7301-6076 | |
| gdc.author.id | Oksel, Ceyda / 0000-0001-5282-4114 | |
| gdc.author.wosid | Winkler, David/A-3774-2008 | |
| gdc.author.wosid | Öksel, Ceyda/AAS-5372-2020 | |
| gdc.bip.impulseclass | C3 | |
| gdc.bip.influenceclass | C4 | |
| gdc.bip.popularityclass | C3 | |
| gdc.coar.access | metadata only access | |
| gdc.coar.type | text::review | |
| gdc.collaboration.industrial | false | |
| gdc.description.department | İzmir Institute of Technology | en_US |
| gdc.description.departmenttemp | [Tomak, Aysel; Cesmeli, Selin; Oksel Karakus, Ceyda] Izmir Inst Technol, Dept Bioengn, Izmir, Turkey; [Hanoglu, Bercem D.] Ardahan Univ, Vocat Sch Hlth Serv, Ardahan, Turkey; [Winkler, David] La Trobe Univ, Sch Biochem & Genet, Bundoora, Vic, Australia; [Winkler, David] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Winkler, David] Univ Nottingham, Sch Pharm, Nottingham, England | en_US |
| gdc.description.endpage | 1357 | en_US |
| gdc.description.issue | 10 | en_US |
| gdc.description.publicationcategory | Diğer | en_US |
| gdc.description.scopusquality | Q1 | |
| gdc.description.startpage | 1331 | en_US |
| gdc.description.volume | 15 | en_US |
| gdc.description.wosquality | Q2 | |
| gdc.identifier.openalex | W4206974976 | |
| gdc.identifier.pmid | 35061957 | |
| gdc.identifier.wos | WOS:000745341000001 | |
| gdc.index.type | WoS | |
| gdc.index.type | PubMed | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 50.0 | |
| gdc.oaire.influence | 3.854931E-9 | |
| gdc.oaire.isgreen | true | |
| gdc.oaire.keywords | Drug Delivery Systems | |
| gdc.oaire.keywords | Nanoparticles | |
| gdc.oaire.keywords | Proteins | |
| gdc.oaire.keywords | Protein Corona | |
| gdc.oaire.keywords | Tissue Distribution | |
| gdc.oaire.popularity | 4.8328065E-8 | |
| gdc.oaire.publicfunded | false | |
| gdc.oaire.sciencefields | 02 engineering and technology | |
| gdc.oaire.sciencefields | 0210 nano-technology | |
| gdc.oaire.sciencefields | 01 natural sciences | |
| gdc.oaire.sciencefields | 0104 chemical sciences | |
| gdc.openalex.collaboration | International | |
| gdc.openalex.fwci | 6.06024678 | |
| gdc.openalex.normalizedpercentile | 0.95 | |
| gdc.openalex.toppercent | TOP 10% | |
| gdc.opencitations.count | 52 | |
| gdc.plumx.mendeley | 61 | |
| gdc.plumx.pubmedcites | 21 | |
| gdc.plumx.scopuscites | 73 | |
| gdc.wos.citedcount | 69 | |
| relation.isAuthorOfPublication.latestForDiscovery | 22db6005-2dcd-426f-abcc-22f964cfa8d5 | |
| relation.isOrgUnitOfPublication.latestForDiscovery | 9af2b05f-28ac-4015-8abe-a4dfe192da5e |
